M.D.C. Stock Forecast, Price & News

M.D.C. (NYSE:MDC) Frequently Asked Questions

Is M.D.C. a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" M.D.C. stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for M.D.C. or view top-rated stocks.

How has M.D.C.'s stock price been impacted by Coronavirus (COVID-19)?

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have increased by 50.8% and is now trading at $51.22.
View which stocks have been most impacted by COVID-19.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release its next quarterly earnings announcement on Tuesday, February 1st 2022.
View our earnings forecast for M.D.C..

How can I listen to M.D.C.'s earnings call?

M.D.C. will be holding an earnings conference call on Tuesday, February 1st at 12:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-344-7529 with passcode "4069820".

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) released its earnings results on Thursday, October, 28th. The construction company reported $1.99 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.01 by $0.02. The construction company had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.36 billion. M.D.C. had a net margin of 11.14% and a trailing twelve-month return on equity of 24.48%. The firm's revenue for the quarter was up 25.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.38 earnings per share.
View M.D.C.'s earnings history.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. announced a quarterly dividend on Friday, October 29th. Stockholders of record on Wednesday, November 10th will be given a dividend of $0.50 per share on Wednesday, November 24th. This represents a $2.00 annualized dividend and a yield of 3.90%. The ex-dividend date of this dividend is Tuesday, November 9th. This is an increase from M.D.C.'s previous quarterly dividend of $0.40.
View M.D.C.'s dividend history.

Is M.D.C. a good dividend stock?

M.D.C. pays an annual dividend of $2.00 per share and currently has a dividend yield of 3.84%. M.D.C. has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of M.D.C. is 26.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 20.94% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

What price target have analysts set for MDC?

4 brokerages have issued 1 year price objectives for M.D.C.'s stock. Their forecasts range from $63.00 to $77.00. On average, they expect M.D.C.'s stock price to reach $67.75 in the next twelve months. This suggests a possible upside of 32.3% from the stock's current price.
View analysts' price targets for M.D.C. or view top-rated stocks among Wall Street analysts.

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the following people:

• David D. Mandarich, President, Chief Executive Officer & Director
• Robert Nathaniel Martin, Senior VP, Chief Financial & Accounting Officer
• Michael Touff, Senior Vice President
• Rebecca B. Givens, Senior Vice President & General Counsel
• Joseph H. Fretz, Secretary, Vice President & Corporate Counsel

Who are some of M.D.C.'s key competitors?

Some companies that are related to M.D.C. include D.R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), Meritage Homes (MTH), KB Home (KBH), Tri Pointe Homes (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Hovnanian Enterprises (HOV) and Beazer Homes USA (BZH).
View all of MDC's competitors.

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by many different institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.06%), Louisiana State Employees Retirement System (0.04%), First Hawaiian Bank (0.02%), Crossmark Global Holdings Inc. (0.02%), Brookstone Capital Management (0.01%) and Wedbush Securities Inc. (0.01%). Company insiders that own M.D.C. stock include David D Mandarich, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C..

Which institutional investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold M.D.C. company stock in the last year include David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, and Robert Nathaniel Martin.
View insider buying and selling activity for M.D.C. or view top insider-selling stocks.

Which institutional investors are buying M.D.C. stock?

MDC stock was bought by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Wedbush Securities Inc., Brookstone Capital Management, Exchange Traded Concepts LLC, First Hawaiian Bank, and Louisiana State Employees Retirement System.
View insider buying and selling activity for M.D.C. or or view top insider-buying stocks.

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $51.22.

How much money does M.D.C. make?

M.D.C. has a market capitalization of $3.62 billion and generates $3.90 billion in revenue each year. The construction company earns $367.58 million in net income (profit) each year or $7.6378 on an earnings per share basis.

How many employees does M.D.C. have?

M.D.C. employs 1,773 workers across the globe.

When was M.D.C. founded?

M.D.C. was founded in 1972.

What is M.D.C.'s official website?

The official website for M.D.C. is www.mdcholdings.com.

Where are M.D.C.'s headquarters?

M.D.C. is headquartered at 4350 S MONACO STREET SUITE 500, DENVER CO, 80237.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at (303) 773-1100, via email at [email protected], or via fax at 303-771-3461.